Saturday, December 7, 2024
A- A A+

Publications

Peer Reviewed Publication from IUCBR & SSH (2021-2020) 

  1.  Williams, Robert J.; Mohanakumar, Kochupurackal P.; Beart, Philip M.Neuro-nutraceuticals: Natural products nourish the brain but be aware of contrary effects. Neurochem Intl.2021
  2. Ranjith GP, Jisha S, Hemanthakumar AS, Saji CV, Shenoi RA, Sabu KK.Impact of potential stimulants on asiaticoside and madecassoside levels and expression of triterpenoid-related genes in axenic shoot cultures of Centella asiatica (L.) Urb.Phytochemistry.2021
  3. Chandra G., Mázala D.A.G., Jaiswal J.K.Coping with the calcium overload caused by cell injury: ER to the rescue.Cell Stress.2021
  4. Govindarajulu M, Ramesh S, Neel L,  Lynd T, Shah K, Mohanakumar K.P, Smith F, Moore T, Dhanasekaran M.Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer’s disease.Neurochem Intl.2021
  5. A Singh Koijam ,…….., Mukhopadhyay, U Rajamma, R Haobam.  Association of Dopamine Transporter Gene with Heroin Dependence in an Indian Subpopulation from Manipur.J Mol Neurosci.2021
  6. Abbina S, Takeuchi LE, Anilkumar P, Yu K, Rogalski JC, Shenoi RA, Constantinescu I, Kizhakkedathu JN.Blood circulation of soft nanomaterials is governed by dynamic remodeling of protein opsonins at nano-biointerface.Nature Communications.2020
  7. A Singh Koijam, B Chakraborty, K Mukhopadhyay, U Rajamma, R Haobam.A single nucleotide polymorphism in OPRM1(rs483481) and risk for heroin use disorder.J Addict Dis.2020
  8. Sumathi T.A., Spinola O., Singh N.C., Chakrabarti B. Perceived Closeness and Autistic Traits Modulate Interpersonal Vocal Communication. Frontiers in Psychiatry.2020
  9. Dutta, D; Chandra, G; Mohanakumar, K P.The light at the end of the tunnel gets vivid for spinal muscular atrophy An Editorial Highlight for Cerebrospinal fluid proteomic profiling in nusinersen-treated patients with spinal muscular atrophy on. J Neurochem. 2020
  10. Chakraborti, B; Verma, D; ………., Mukhopadhyay, K; Mohanakumar, K P.; Rajamma, U. Gender-Specific Effect of 5-HT and 5-HIAA on Threshold Level of Behavioral Symptoms and Sex-Bias in Prevalence of Autism Spectrum Disorder. Front Neurosci.2020
  11. Sarkar C, Sadhukhan T, Bagh MB, Appu AP, Chandra G, Mondal A, Saha A, Mukherjee AB.Cln1-mutations suppress Rab7-RILP interaction and impair autophagy contributing to neuropathology in a mouse model of infantile neuronal ceroid lipofuscinosis. J Inherit Metab Dis.2020
  12. S Saha, T Saha , S Sinha, U Rajamma, K Mukhopadhyay. Autistic traits and components of the folate metabolic system: an explorative analysis in the eastern Indian ASD subjects. NutrNeurosci. 2020

 

Peer Reviewed Publication from IUCBR & SSH (2015-2019) 

  1. Chandra G*, Shenoi RA*, Anand R, Rajamma U, Mohanakumar KP. Reinforcing mitochondrial functions in aging brain: An insight into Parkinson’s disease therapeutics. J Chem Neuroanat. 2019, 95, 29-42.
  2. Pandey M, Rajamma U. Huntington’s disease: the coming of age. J Genet. 2018 Jul;97(3):649-664.
  3. Raju TR, Mohanakumar KP. Neural functions of the aging brain: Daily living, developmental and geriatric disabilities. J Chem Neuroanat. 2019 Jan; 95:1-5.
  4. Raju A, Jaisankar P, Borah A, Mohanakumar KP. 1-Methyl-4-Phenylpyridinium-Induced Death of Differentiated SH-SY5Y Neurons Is Potentiated by Cholesterol. Ann Neurosci. 2018 May;24(4):243-251.
  5. Singh A, Verma P, Raju A, Mohanakumar KP. Nimodipine attenuates the parkinsonian neurotoxin, MPTP-induced changes in the calcium binding proteins, calpain and calbindin. J Chem Neuroanat. 2019 Jan; 95:89-94.
  6. Karmakar A, Goswami R, Saha T, Maitra S, Roychowdhury A, Panda CK, Sinha S, Ray A, Mohanakumar KP, Rajamma U, Mukhopadhyay K. Pilot study indicate role of preferentially transmitted monoamine oxidase gene variants in behavioral problems of male ADHD probands. BMC Med Genet. 2017 Oct 5;18(1):109
  7. Nthenge-Ngumbau DN, Mohanakumar KP. Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson’s Disease? Mol Neurobiol. 2018 Jan;55(1):822-834.
  8. Dutta D, Ali N, Banerjee E, Singh R, Naskar A, Paidi RK, Mohanakumar KP. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson’s Disease. Mol Neurobiol. 2018 Jan;55(1):804-821.
  9. Verma P, Singh A, Nthenge-Ngumbau DN, Rajamma U, Sinha S, Mukhopadhyay K, Mohanakumar KP. Attention deficit-hyperactivity disorder suffers from mitochondrial dysfunction. BBA Clin. 2016 Oct 18;6:153-158.
  10. Singh A, Verma P, Balaji G, Samantaray S, Mohanakumar KP. Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Neurochem Int. 2016 Oct;99:221-232.
  11. Chakraborti B, Verma D, Karmakar A, Jaiswal P, Sanyal A, Paul D, Sinha S, Singh AS, Guhathakurta S, Roychowdhury A, Panda CK, Ghosh S, Mohanakumar KP, Mukhophadhyay K, Rajamma U. Genetic variants of MAOB affect serotonin level and specific behavioral attributes to increase autism spectrum disorder (ASD) susceptibility in males. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Nov 3;71:123-36.
  12. Karmakar A, Maitra S, Chakraborti B, Verma D, Sinha S, Mohanakumar KP, Rajamma U, Mukhopadhyay K. Monoamine oxidase B gene variants associated with attention deficit hyperactivity disorder in the Indo-Caucasoid population from West Bengal. BMC Genet. 2016 Jun 24;17(1):92.
  13. Chakrabarti S, Mohanakumar KP. Aging and Neurodegeneration: A Tangle of Models and Mechanisms. Aging Dis. 2016 Mar 15;7(2):111-3.
  14. Williams RJ, Mohanakumar KP, Beart PM. Neuro-nutraceuticals: Further insights into their promise for brain health. Neurochem Int. 2016 May;95:1-3.
  15. Williams RJ, Mohanakumar KP, Beart PM. Neuro-nutraceuticals: The path to brain health via nourishment is not so distant. Neurochem Int. 2015 Oct;89:1-6.

Papers published after the Scientists joined IUCBR, and where IUCBR name features in the article

  1. Schmitt V, Rodríguez-Rodríguez C, Hamilton JL, Shenoi RA, Schaffer P, Sossi V, Kizhakkedathu JN, Saatchi K and Häfeli UO. Quantitative SPECT imaging and biodistribution point to molecular weight independent tumor uptake for some long-circulating polymer nanocarriers. RSC Advances 8, 5586-5595 (2018). (IF: 3.108).
  2. Kalathottukaren MT, Srinivas A, Yu K, Shenoi RA, Creagh AL. Haynes CA and Kizhakkedathu, JN. A polymer therapeutic having universal heparin reversal activity: molecular design and functional mechanism. Biomacromolecules 18, 3343-3358 (2017) (IF: 5.246).
  3. Wong NKY, Shenoi RA, Abbina S, Chafeeva I, Kizhakkedathu JN and Khan MK.  Non-transformed and cancer cells can utilize different endocytic pathways to internalize dendritic polymer nanoparticle variants: implications on nanocarrier design.  Biomacromolecules 18, 2427-2438 (2017) (IF: 5.246).
  4. Kalathottukaren MT, Abraham L, Kapopara PK, Lai BFL, Shenoi RA, Rosell FI, Conway EM, Pryzdial ELG, Morissey JH, Haynes CA and Kizhakkedathu JN. Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor, UHRA. Blood 129, 1368-1379 (2017) (IF: 13.164).
  1. Saha S, Saha T, Sinha S, Rajamma U, Mukhopadhyay K. Autistic traits and components of the folate metabolic system: an explorative analysis in the eastern Indian ASD subjects . Nutr Neurosci. 2019 Jan 24;:1-8. doi: 10.1080/1028415X.2019.1570442. [Epub ahead of print] PubMed PMID: 30676283.
  2. Saha T, Chatterjee M, Verma D, Ray A, Sinha S, Rajamma U, Mukhopadhyay K. Genetic variants of the folate metabolic system and mild hyperhomocysteinemia may affect ADHD associated behavioral problems. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jun 8;84(Pt A):1-10. doi: 10.1016/j.pnpbp.2018.01.016. Epub 2018 Jan 31. PubMed PMID: 29407547.
  3. Karmakar A, Goswami R, Saha T, Maitra S, Roychowdhury A, Panda CK, Sinha S, Ray A, Mohanakumar KP, Rajamma U, Mukhopadhyay K. Pilot study indicate role of preferentially transmitted monoamine oxidase gene variants in behavioral problems of male ADHD probands. BMC Med Genet. 2017 Oct 5;18(1):109. doi: 10.1186/s12881-017-0469-5. PubMed PMID: 28982350; PubMed Central PMCID: PMC5629801.
  4. Saha T, Chatterjee M, Sinha S, Rajamma U, Mukhopadhyay K. Components of the folate metabolic pathway and ADHD core traits: an exploration in eastern Indian probands. J Hum Genet. 2017 Jul;62(7):687-695. doi: 10.1038/jhg.2017.23. Epub 2017 Mar 2. PubMed PMID: 28250422.